There is a reason Brighton Savoy has become increasingly interested in reviewing supplements marketed to Australians with diabetes, neuropathy, blood-sugar concerns and related health conditions.

We are seeing an extraordinary amount of advertising.

Some products are promoted with relatively modest claims about supporting general health. Others are marketed much more aggressively, using phrases about blood sugar, metabolism, nerves, liver health, GLP-1, weight loss or dramatic improvements in wellbeing.

Sometimes the marketing looks more impressive than the evidence we can find behind the finished product.

That is where our interest begins.

We are not opposed to supplements.

We are not trying to prove that every supplement is ineffective.

And we do not believe that the absence of perfect evidence automatically means a product has no value.

Our position is much simpler:

If a company makes a health claim to consumers, we think people should be able to examine what is actually in the product, how much is in it, what evidence supports the claims, how the product is regulated and whether the advertising fairly reflects what is known.

That is the standard we try to apply to our independent supplement reviews.

Readers can also explore our Complete Guide to Diabetes Supplements in Australia, which brings together our individual product investigations and broader consumer research.

Why Diabetes Supplement Claims Deserve More Scrutiny

There is a significant difference between buying an ordinary consumer product and buying something because you hope it will improve your health.

If a household gadget does not work particularly well, you may have wasted some money.

Health products are different.

Someone purchasing a supplement marketed around blood glucose, neuropathy, metabolism or another health concern may be doing so because they are worried, uncomfortable or actively looking for something that may help.

That makes the quality of the information surrounding the product especially important.

We become particularly cautious when advertising suggests a supplement can:

• dramatically reduce blood glucose;
• substantially lower HbA1c;
• reverse or cure diabetes;
• replace medication;
• provide an effect comparable with prescription medicines;
• “activate GLP-1” in a way that implies a pharmaceutical-like result;
• repair nerve damage;
• produce rapid weight loss; or
• achieve another major medical outcome without strong supporting evidence.

An ingredient can have legitimate scientific research behind it without proving that a particular commercial supplement will produce the result implied by its advertising.

That distinction sits at the centre of our review methodology.

Ingredient Evidence Is Not the Same as Product Evidence

This is one of the most important concepts for consumers to understand.

Imagine a supplement contains Ingredient X.

Researchers have studied Ingredient X and found an interesting effect in a particular group of people.

A supplement company may then highlight that research when promoting a product containing Ingredient X.

But several questions remain:

• Was the finished commercial product actually studied?
• Was the ingredient used in the research chemically equivalent to the ingredient in the supplement?
• Was the dose comparable?
• How long did participants take it?
• Who participated in the study?
• Was the study randomised and controlled?
• How large was the study?
• Was the outcome clinically meaningful?
• Did the research investigate the same outcome being suggested in the advertisement?

Those questions matter.

A study of an individual ingredient is not automatically a clinical trial of every commercial product containing that ingredient.

This is one reason Brighton Savoy pays particular attention to whether advertising refers to evidence about an ingredient or evidence involving the actual finished formulation.

Dose Matters More Than an Impressive Ingredient List

One of the most common problems we encounter is what might be called ingredient-list marketing.

A product may advertise a long list of fashionable ingredients such as berberine, cinnamon, chromium, alpha-lipoic acid, magnesium, turmeric, herbal extracts, vitamins and antioxidants.

The list can look impressive.

But the more useful question is:

How much of each ingredient is actually in the recommended daily dose?

The presence of an ingredient and the dose of that ingredient are two different things.

If research investigated a particular ingredient at a certain dose, a product containing only a fraction of that amount should not automatically be assumed to produce the same effect.

That does not necessarily make the product useless.

It does mean the research needs to be interpreted carefully.

This is why our reviews try to examine the Supplement Facts panel, ingredient list or Australian medicine label rather than relying only on a company’s promotional page.

Where the exact amount of an ingredient is not disclosed, we say so.

Where a proprietary blend prevents consumers from knowing how much of each ingredient is present, we treat that as an important limitation.

How Supplements Are Regulated in Australia

Australian consumers frequently misunderstand what an AUST number means.

Medicines supplied in Australia may be included in the Australian Register of Therapeutic Goods (ARTG) and display an AUST L, AUST L(A) or AUST R number depending on their regulatory pathway.

These categories are not interchangeable.

AUST L: Listed Medicines

Many vitamins, herbal preparations and complementary medicines sold in Australia are listed medicines and display an AUST L number.

These are generally considered lower-risk medicines.

An AUST L number tells consumers that the product is included in the ARTG.

However, consumers should not interpret AUST L as meaning the TGA has individually assessed the finished product before sale and concluded that it is clinically effective for every outcome a consumer may associate with its marketing.

Sponsors of listed medicines still have regulatory obligations, including requirements relating to ingredients, indications and supporting evidence.

That is meaningful regulatory oversight.

But it is not the same as the pre-market efficacy assessment applied through some other regulatory pathways.

AUST L(A): Assessed Listed Medicines

An AUST L(A) medicine has gone through an additional assessment pathway.

These medicines may make certain intermediate-level indications, with supporting evidence assessed by the TGA as part of that pathway.

AUST R: Registered Medicines

An AUST R number identifies a registered medicine.

Registered medicines are subject to a higher level of pre-market evaluation, including assessment relating to safety, quality and efficacy.

Why We Check the AUST Number

When reviewing an Australian therapeutic product, Brighton Savoy may check:

• whether it has an AUST L, AUST L(A) or AUST R number;
• whether that number corresponds with the product being marketed;
• the ARTG information available for the product;
• its permitted or approved indications where relevant; and
• whether the marketing appears consistent with its regulatory status.

An AUST number is useful information.

But it needs to be interpreted correctly.

“Listed with the TGA” and “clinically proven by the TGA” are not the same statement.

Consumers can read the Therapeutic Goods Administration’s explanation of AUST numbers on medicine labels.

Marketing Claims Are Part of Our Review

We do not assess only the capsule, tablet, powder or cream.

We also assess the way it is being sold.

Consumers do not encounter health products in a laboratory.

They encounter advertisements.

Those advertisements can use before-and-after stories, testimonials, dramatic headlines, scientific terminology, graphs, health professionals or people presented as experts, limited-time offers and comparisons with other treatments.

Our reviews therefore consider the overall impression created by the marketing.

A technically qualified sentence buried in fine print does not necessarily tell us whether the prominent advertising gives consumers a balanced understanding of the available evidence.

Advertising Patterns That Make Us Look More Closely

None of the following automatically proves that a product is ineffective or that a company has done anything wrong.

They simply make us investigate more carefully.

1. Pharmaceutical Comparisons

Phrases suggesting a supplement works “like Ozempic”, “like a GLP-1” or in a way comparable with prescription treatment deserve particular scrutiny.

Biological plausibility is not the same thing as demonstrating a comparable clinical outcome.

2. Dramatic Before-and-After Claims

Large changes in weight, glucose measurements, pain or other health outcomes require context and credible evidence.

Individual testimonials cannot establish what the average consumer should expect.

3. “Clinically Proven” Language

When we see words such as clinically proven, clinically tested or scientifically proven, we look for the underlying evidence.

Was the actual finished product studied?

Or does the evidence relate only to one or more ingredients?

The Root of Nature R-ALA investigation is a particularly useful example of why we ask this question.

4. Long Ingredient Lists Without Useful Dose Information

A long list can create an impression of potency while telling consumers relatively little about whether meaningful quantities are present.

5. Heavy Reliance on Testimonials

Customer experiences can be useful.

They may identify patterns involving taste, delivery, customer service, subscriptions, refunds or side effects.

But testimonials are not substitutes for controlled clinical evidence.

6. Artificial Urgency

Countdown timers, repeated “today only” discounts, low-stock warnings and constant promotional pricing do not tell consumers whether a health product works.

We separate those sales techniques from the evidence for the product itself.

7. Claims Much Stronger Than the Evidence

An ingredient may have preliminary research suggesting a possible benefit.

That does not necessarily justify presenting the outcome as established fact.

The greater the health claim, the stronger we expect the supporting evidence to be.

How Brighton Savoy Independently Reviews Supplements

We want readers to understand how we reach our conclusions.

Our reviews generally follow the process below.

Step 1: Identify the Exact Product

We establish what is actually being reviewed.

That can include:

• product name;
• manufacturer or sponsor;
• formulation;
• recommended dose;
• Australian regulatory status where relevant;
• pack size; and
• current advertised price.

This matters because formulations, labels and product names can change.

Step 2: Capture the Claims Being Made

We examine what the company actually tells consumers.

That can include claims made on:

• the official website;
• product packaging;
• dedicated landing pages;
• social-media advertisements;
• comparison graphics;
• FAQs;
• advertorials; and
• other promotional material we can reliably identify.

We distinguish between modest support claims and much stronger claims implying treatment, reversal, cure or pharmaceutical-like effects.

Step 3: Examine the Ingredient Panel

We look at what is actually in the product.

Where possible, we record:

• active ingredients;
• quantity per tablet, capsule or serving;
• recommended daily dose;
• proprietary blends;
• excipients where relevant; and
• important warnings appearing on the label.

Photographs of the actual label are particularly useful because marketing pages do not always present ingredient information with the same prominence as promotional claims.

Where the exact amount of an ingredient is not disclosed, we say so.

Step 4: Compare the Dose With Relevant Research

This is one of the most important stages.

If a company highlights research involving an ingredient, we look at whether the quantity in the commercial product is reasonably comparable with the dose used in relevant human research.

We also consider study duration and population where those factors materially affect the comparison.

We do not assume that simply including an ingredient means a commercial product reproduces the results of research involving that ingredient.

Our Metagenics NeuroCalm independent review is one example. We examined the evidence relating to individual herbal ingredients while distinguishing that research from evidence involving the complete commercial formulation.

Step 5: Look for Evidence Involving the Finished Product

We search for evidence involving the actual commercial formulation where appropriate.

If the finished product itself has been studied, that can be considerably more informative than extrapolating from unrelated studies involving individual ingredients.

If we cannot find product-specific clinical evidence, we say so.

Step 6: Check Australian Regulatory Information Where Relevant

For products supplied as therapeutic goods in Australia, we may examine ARTG information and the AUST number displayed on the product.

We try to explain what that regulatory classification means without overstating it.

Step 7: Examine Safety and Important Limitations

We consider known warnings, possible interactions and circumstances where consumers should seek professional advice.

We do not attempt to provide individual medical advice.

Step 8: Examine the Commercial Proposition

Effectiveness is only one part of a consumer review.

We may also examine:

• price;
• quantity supplied;
• recommended daily dose;
• approximate monthly cost;
• subscription terms;
• automatic renewals;
• refund policy;
• money-back guarantees;
• shipping;
• contact information; and
• whether important commercial conditions are clearly disclosed.

A supplement can contain legitimate ingredients and still represent poor value.

Step 9: Separate Consumer Experience From Scientific Evidence

Customer reviews can be informative, but we treat them differently from clinical evidence.

We may consider customer feedback when examining:

• service;
• delivery;
• billing;
• refund experiences;
• product usability; and
• recurring complaint patterns.

We do not treat testimonials as proof that a supplement prevents, treats or cures a medical condition.

Step 10: Reach a Proportionate Conclusion

Our aim is not to label every product either “amazing” or a “scam”.

Real evidence is usually more complicated.

A product may contain sensible ingredients but use aggressive advertising.

Another may have transparent labelling but limited evidence for the outcome consumers expect.

Another may be reasonably formulated but expensive compared with simpler alternatives.

Our conclusions therefore try to explain:

• What appears credible?
• What is supported?
• What remains uncertain?
• What concerns us?
• Does the marketing go further than the available evidence reasonably supports?

What Evidence Is Most Useful to Us?

When assessing or updating a supplement review, the most useful information generally includes:

• the current product label;
• current ingredient quantities;
• ARTG information where relevant;
• product-specific clinical trials;
• published peer-reviewed research;
• evidence supporting specific advertising claims;
• current pricing;
• refund and subscription terms; and
• documentation capable of correcting a specific factual statement in our review.

Marketing brochures alone are less useful than primary documentation.

Where reliable evidence warrants a correction, we will consider it.

Blood Sugar Supplements Are Not Harmless Just Because They Are “Natural”

The word natural is powerful marketing.

It is not a guarantee of safety.

Plants contain biologically active compounds.

Vitamins and minerals can be harmful at inappropriate doses.

Ingredients can interact with prescription medicines.

Combining several products can also expose consumers to larger quantities of particular ingredients than they realise.

This is especially important for people managing diabetes.

If a supplement genuinely influences blood glucose, combining it with glucose-lowering medication could potentially alter glucose control.

If it does not meaningfully influence blood glucose, then advertising that strongly implies it does presents a different problem.

Either way, consumers deserve accurate information.

Why We Are Particularly Cautious About “Natural Ozempic” and GLP-1 Claims

GLP-1 has become an extraordinarily powerful marketing term.

Prescription GLP-1 receptor agonist medicines have produced substantial clinical outcomes in appropriate patients and have therefore generated enormous public interest.

That creates a marketing opportunity.

An ingredient that affects a biological pathway associated with GLP-1 in laboratory research is not automatically equivalent to a prescription GLP-1 receptor agonist.

Those are very different propositions.

When a supplement is advertised using language that encourages consumers to associate it with prescription medicines, we look closely at:

• what effect was actually demonstrated;
• whether the research involved humans;
• the dose;
• the magnitude of the effect;
• whether the finished product was tested; and
• whether the advertising communicates those limitations fairly.

This is an area where consumers should be particularly sceptical of dramatic shortcuts.

Why We Don’t Automatically Call a Product a Scam

Online product reviews often gravitate towards two extremes:

Miracle or scam.

We do not think that is particularly useful.

A more accurate conclusion may be that:

• evidence is limited;
• doses appear low compared with relevant studies;
• marketing overstates the available evidence;
• product-specific research was not found;
• pricing is high;
• particular claims require more substantiation; or
• the product appears reasonable but consumer expectations should remain modest.

Those descriptions are usually more useful than simply shouting SCAM or MIRACLE.

For example, in our Root of Nature R-ALA review, we found legitimate research behind alpha-lipoic acid and the 600mg dose, while still identifying important limitations in applying that research directly to the finished commercial product.

The Questions We Think Every Consumer Should Ask

Before buying a supplement marketed for blood sugar, neuropathy, metabolism, liver health or another significant health concern, ask:

1. What exactly is the product claiming to do?
2. What are the active ingredients?
3. How much of each ingredient will I actually take per day?
4. Were those doses used in relevant human studies?
5. Has the finished product itself been clinically studied?
6. Does it have an Australian AUST number where one would be expected?
7. What does that particular regulatory classification actually mean?
8. Could it interact with my medicines or other supplements?
9. What will it cost me per month at the recommended dose?
10. Is there an automatic subscription?
11. What exactly is the refund policy?
12. Are dramatic advertising claims supported by evidence I can actually inspect?

If a company makes it difficult to answer basic questions about dose, evidence or price, that is information in itself.

Our Diabetes Supplement and Neuropathy Research

Brighton Savoy has developed a growing collection of independent consumer investigations covering supplements and products marketed around diabetes, blood glucose and neuropathy.

Useful starting points include:

• Complete Guide to Diabetes Supplements in Australia – our central guide to the category and individual product reviews.
• Diabetic Neuropathy Relief: Do Creams and Tablets Really Work? – our broader examination of products promoted for diabetic nerve symptoms.
• Root of Nature R-Alpha Lipoic Acid 600mg Review – our investigation into the evidence behind R-ALA, the 600mg dose and whether the major clinical trials actually tested Root of Nature.
• FlexiNerve Independent Review – examining a multi-ingredient supplement marketed for neuropathy.
• Inner Dose Nerve Relief Cream Review – examining topical nerve-relief claims and the distinction between temporary symptom relief and treating underlying neuropathy.

Why Brighton Savoy Publishes These Reviews

Brighton Savoy has changed considerably from its origins as a Melbourne hotel and wedding venue.

Today, part of our publishing work involves consumer research.

We became interested in supplement marketing because consumers increasingly encounter sophisticated health advertising through social media, search engines, advertorials and online stores.

It can be remarkably difficult to distinguish between:

• an ingredient with interesting preliminary evidence;
• a reasonably formulated complementary medicine;
• a product containing ingredients supported at relevant doses; and
• a commercial product being promoted beyond what the available evidence comfortably supports.

That is why we have developed both individual product reviews and our broader Australian diabetes supplement consumer guide.

We think there is value in slowing the purchasing process down.

Read the label. Check the dose. Find the evidence. Understand the regulatory status. Examine the advertisement. Check the price. Look at the refund terms. Then make a decision.

Why We’re Still Frustrated

The frustration that prompted the original version of this article remains.

It is not because we expect every supplement to undergo enormous pharmaceutical-style clinical trials.

It is not because we believe complementary medicines have no place in healthcare.

And it is not because every company marketing a supplement is behaving irresponsibly.

Our frustration comes from the gap that can sometimes develop between what the evidence actually shows and what a consumer may reasonably think an advertisement is promising.

Consumers managing diabetes, neuropathy or another chronic health concern are not an abstract marketing demographic.

They are people looking for answers.

Sometimes they are looking for hope.

That creates a responsibility.

Manufacturers should describe their products accurately.

Publishers should disclose commercial relationships.

Reviewers should distinguish clinical evidence from testimonials.

And consumers should be given enough information to make an informed decision.

That is the standard we will continue trying to apply.

Related Brighton Savoy Consumer Research

• Complete Guide to Diabetes Supplements in Australia
• Diabetic Neuropathy Relief: Do Creams and Tablets Really Work?
• Root of Nature R-Alpha Lipoic Acid 600mg Review
• FlexiNerve Independent Product Review
• Inner Dose Nerve Relief Cream Review
• About Brighton Savoy and Our Consumer Research